CTSO
Cytosorbents Corp
NASDAQ · Healthcare · Medical - Devices · US
$4.56
+0.44%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- 7.20x
- P/S forward
- 0.32x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- -19.08x
- Price / sales
- 0.38x
- Price / cash flow
- -1.39x
Enterprise value
- Enterprise value
- $36.2M
- EV / sales
- 0.97x
- EV / EBITDA
- -2.60x
- EV / EBIT
- -2.92x
- Market cap
- $14.3M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026